Gavis Pharmaceuticals

An innovative developer of generic pharmaceuticals, Gavis pursues difficult-to-manufacture medicines with sophisticated drug-delivery profiles or novel dosage forms. The company merged with Lupin Pharmaceuticals in 2016.